4.6 Article

Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Effects of thalidomide on isoprenaline-induced acute myocardial injury: A haemodynamic, histopathological and ultrastructural study

Harish K. Loh et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)

Article Pharmacology & Pharmacy

Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation

Ana Paula C. Davel et al.

BRITISH JOURNAL OF PHARMACOLOGY (2006)

Article Biochemistry & Molecular Biology

Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes

QA Li et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Cytokines and vascular reactivity in resistance arteries

E Vila et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)

Article Biochemistry & Molecular Biology

β-adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB

B Chandrasekar et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Article Biochemistry & Molecular Biology

Inhibition of NF-κB activity by thalidomide through suppression of IκB kinase activity

JA Keifer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Hematology

Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice

LV d'Uscio et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)

Article Cardiac & Cardiovascular Systems

Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression

DR Murray et al.

CIRCULATION (2000)

Review Cardiac & Cardiovascular Systems

β-adrenergic receptor blockade in chronic heart failure

MR Bristow

CIRCULATION (2000)

Article Cardiac & Cardiovascular Systems

Antiproliferative effects of trapidil in vascular smooth muscle cells are associated by inhibition of MAPK and P34(cdc2) activity

Y Cheng et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)